Skip to content

Study · Animal study (in vivo) · mouse · 1998

1 result

Leuprolide, a gonadotropin-releasing hormone agonist, enhances colonization after spermatogonial transplantation into mouse testes.

Ogawa T, Dobrinski I, Avarbock MR, Brinster RL

Tissue & cell1 Oct 1998Cited by 61 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: CC BY-NC-ND. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. No result from this study comes from people.

  1. 01AnimalAnimal study (in vivo)Efficacy outcome

    In busulfan-treated recipient mice, leuprolide enhanced donor cell colonization versus untreated controls, assessed 3 months after transplantation.

    In plain wordsIn mice, leuprolide enhanced donor cell colonization versus untreated controls at assessment 3 months after transplantation.

    Peptide
    Leuprolide
    Outcome
    IncreaseDonor cell colonization
    Study

    mousen = 6

    Busulfan-treated recipient mice undergoing spermatogonial transplantation
    Comparator
    Untreated control mice
    Outcome group
    Sex hormones and fertility · Reproductive and sexual health
    Studied dose
    Dose not stated · injectionAs given in this study (mouse).

    Source sentences

    Summary
    Efficiency of colonization by donor cells was markedly enhanced in recipient mice treated with the GnRH agonist leuprolide acetate,
    2 context sentences
    Summary · context
    Six recipient mice were treated with busulfan to destroy endogenous spermatogenesis followed by injection of leuprolide acetate to three of the mice.
    Summary · context
    The extent of donor cell colonization was compared between leuprolide treated recipients and untreated control mice 3 months after transplantation.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    28 Oct 2026, 02:03 UTC

    Study results updated

  2. Version 1

    27 Oct 2026, 16:37 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.